Amphotericin B
- TRADE NAMES: Abelcet (Sigma-Tau); AmBisome (Astellas); Amphocin (Pfizer); Amphotec (Alkopharma); Fungilin; Fungizone
- INDICATIONS: Potentially life-threatening fungal infections
- CLASS: Antifungal / antimycotic, Antimicrobial
- HALF-LIFE: initial: 15–48 hours; terminal: 15 days
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Adefovir, Aminoglycosides, Arsenic, Astemizole, Betamethasone, Cephalothin, Cidofovir, Cyclosporine, Digoxin, Ethoxzolamide, Fluconazole, Flucytosine, Ganciclovir, Griseofulvin, Hydrocortisone, Itraconazole, Ketoconazole, Micafungin, Pentamidine, Probenecid, Sulpiride, Terbinafine, Triamcinolone, Voriconazole
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OTIC.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 01/28/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
